Showing results (351-360 of 901) with videos related to

Sort By:
Pageof 91
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1992
Interferon alfa-2a and fluorouracil in the treatment of patients with advanced esophageal cancerD Kelsen, D Lovett, J Wong, et al.
Cancer Investigation|April 1, 1999
A phase II trial of interferon alpha-2a and carboplatin in patients with advanced malignant mesotheliomaE M O'Reilly, D H Ilson, L B Saltz, et al.
Journal of Digital Imaging|November 28, 2007
A knowledge-anchored integrative image search and retrieval systemSelnur Erdal, Umit V Catalyurek, Philip R O Payne, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|August 13, 2008
Integrating heterogeneous rules-engine technologies with caGridJoel H Saltz, Scott Oster, Shannon L Hastings, et al.
Pain Medicine (Malden, Mass.)|May 10, 2012
Home-based aerobic conditioning for management of symptoms of fibromyalgia: a pilot studyR Norman Harden, Sharon Song, Jo Fasen, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1999
Conservative management of rectal cancer with local excision and postoperative adjuvant therapyR Wagman, B D Minsky, A M Cohen, et al.
Journal of the National Cancer Institute|December 14, 2019
Lack of Availability and Efficacy of Phase I and Basket Trials for Patients With Gastrointestinal CancersRajiv Agarwal, Nicholas A Cangemi, Andrew S Epstein, et al.
Clinical Trials (London, England)|January 29, 2019
Challenges and solutions in the design and execution of the PROSPECT Phase II/III neoadjuvant rectal cancer trial (NCCTG N1048/Alliance)Deborah Schrag, Martin Weiser, Leonard Saltz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesotheliomaV Rusch, L Saltz, E Venkatraman, et al.
Clinical Colorectal Cancer|March 16, 2016
A Phase II Efficacy and Safety, Open-Label, Multicenter Study of Imprime PGG Injection in Combination With Cetuximab in Patients With Stage IV KRAS-Mutant Colorectal CancerNeil H Segal, Purvi Gada, Neil Senzer, et al.
Pageof 91